Back to Top
Go Back
Journal Photo for European Heart Journal
Peer reviewed only Open Access

European Heart Journal (EHJ)

Publisher : Oxford University Press
Medicine Cardiology Cardiovascular Medicine
Claim Your Journal Get PRC Visit Website
e-ISSN 1522-9645
p-ISSN 0195-668X
Issue Frequency weekly
Impact Factor 39.3
Est. Year 1980
Mobile 4401536452640
Language English
APC YES
Impact Factor Assignee Google Scholar
Email enquiry@oup.co.uk

Journal Descriptions

The European Heart Journal is an international, English language, peer-reviewed journal dealing with cardiovascular medicine. It is an official journal of the European Society of Cardiology and is published weekly. The European Heart Journal aims to publish the highest quality material, both clinical and scientific, on all aspects of cardiovascular medicine. It includes articles related to research findings, technical evaluations, and reviews. In addition it provides a forum for the exchange of information on all aspects of cardiovascular medicine, including education issues. In addition to publishing original papers on all aspects of cardiovascular medicine and surgery, the journal also features reviews, clinical perspectives, ESC Guidelines, and editorial articles about recent developments in cardiology as well as encouraging correspondence from its readers.

European Heart Journal (EHJ) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine, Cardiology, Cardiovascular Medicine , Online or Print , weekly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0195-668X, E-ISSN: 1522-9645, Established: 1980, Impact Factor: 39.3
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of EHJ

Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study
Emelia J. Benjamin March, 2004
Aims Hyperhomocysteinaemia is a risk factor for congestive heart failure, especially in women. We investigated if homocysteine promotes left ventricular (LV) remodelling. Methods and resu...
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study
Emelia J. Benjamin September, 2004
Aims Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a key regulator of extracellular matrix degradation. We examined relations of plasma total TIMP-1 to cardiovascular risk factors and...
Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke
Emelia J. Benjamin November, 2013
Aims Atrial fibrillation increases the risks of stroke, heart failure, and death, and anticoagulation therapy increases the risk of gastrointestinal haemorrhage. However, the relative event...
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation
Emelia J. Benjamin January, 2009
Aims A recent genome-wide association study identified a haplotype block on chromosome 4q25 associated with atrial fibrillation (AF). We sought to replicate this association in four indepen...
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Emelia J. Benjamin July, 2013
Aims Since atrial fibrillation (AF) is associated with increased risks of cardiovascular and cerebrovascular complications, estimations on the number of individuals with AF are relevant to ...
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the m...
Emelia J. Benjamin August, 2011
Guidelines summarize and evaluate all available evidence, at the time of the writing process, on a particular issue with the aim of assisting physicians in selecting the best management stra...
Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg...
C. Noel Bairey Merz January, 2018
A variety of observations suggest that coronary microvascular dysfunction (CMD) is related to the pathogenesis of cardiovascular disease, including myocardial ischaemia and heart failure.1,2...
Heart–brain interactions in cardiac and brain diseases: why sex matters
C. Noel Bairey Merz October, 2022
Cardiovascular disease and brain disorders, such as depression and cognitive dysfunction, are highly prevalent conditions and are among the leading causes limiting patient’s quality of lif...
Gender in cardiovascular medicine: chest pain and coronary artery disease
C. Noel Bairey Merz November, 2019
Ischaemic heart disease (IHD) remains the leading cause of morbidity and mortality among women and men yet women are more often underdiagnosed, have a delay in diagnosis, and/or receive subo...
The Yentl syndrome is alive and well
C. Noel Bairey Merz March, 2011
This editorial refers to ‘Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain?’†, by N. Johnston et al., on page 1331and‘F...